上海相关职位： 药物工艺研究员 有机合成高级研究员 医药技术研发分析研究人员 OTC销售代表 医药研发项目组长 医药研发员 化药原料药研究员/高级研究员 化药原料药助理研究员/研究员 化药原料药研究员/高级研究员 医药研发员
周边城市招聘： 上海 浙江 安徽 广东 山东 河北 重庆 北京 江苏 湖南
企业入驻日期： 2017-11-09
-
无工作经验 -
本科 -
招若干人 -
11-09 发布
- 五险一金
- 交通补贴
- 餐饮补贴
- 通讯补贴
- 专业培训
- 出国机会
- 定期体检
职位描述
职位描述： Responsibility for Project Manager?Ensure that the clinical studies are performed according to existing laws and regulations (ICH-GCP, CFDA-GCP).?Ensure that studies are performed according to CCBR standard procedures and quality regulations.?Plan, implement and drive all aspects of clinical studies in compliance with GCP.?Ensure that the clinical studies are performed according to the protocols.?Ensure that patient data is handled according to the national Data Protection law, if any.?Ensure that project tasks conform with the scope of the project and any signed agreements between CCBR and clients.?Develop and maintain close working relationship with BD to ensure clients satisfaction, operational and customer service excellence.?Lead the project team to fulfill the project requirements and meet the client’s need .?Ensure that all staff involved in study have received the relevant training and new information before and during the study procedures.?Proactively communicate the status of ongoing projects, issues, and risks that may affect the clinical trial and project schedule with internal team.?Communicate reglularly with investigator sites and vendors to ensure smooth study set up and maintain exceptional study conduct, review site performance, and identify and be aware of site/study issues.?Conduct motivational visits, as well as, develop materials and initiatives to support patient recruitment and retention with each site.?Acts as main contact for study sites and sponsors and provide answers to study and device-related questions.?Ensure management is well informed on project progression and revenue tracking. 职能类别： 生物工程/生物制药 关键字： 项目经理 PM
联系方式
上海
公司信息
CCBR，临床与基础研究集团公司（Clinical and Basic Research Group）由全球骨质疏松领域的开拓者与领航者Dr.Claus Christiansen于1992年创办。总部位于丹麦，是一家专门从事临床药物研究的集团公司。在全球17个国家有40多家研究型医院（即临床研究中心）,并且我们提供全球一流的医学影像学分折技术及心血管安全指标分析。 西斯比亚（北京）医药技术研究有限责任公司是CCBR在中国区的子公司，创办于2005年9月。作为全球领先的SMO集团，CCBR是国内仅有的全外资SMO。在中国的业务主要包括与国内各大医院按GCP原则联合开展临床研究以及外派临床研究协调员（CRC）业务。目前我们在全国50多个城市200多家医院有CRC业务。
